Biotech · Private company
Nucleix Ltd.
Track this companyFree. Adds Nucleix Ltd. to your Dealase workspace and tells you when its record changes.
Clinical trials61 recruiting or active
Pipeline programs6From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline6
- Bladder EpiCheckNon Muscle Invasive Bladder CancerClinicalTrials.gov · fetched Nov 12, 2026
- Bladder EpiCheckSuspicion of Bladder CancerClinicalTrials.gov · fetched Nov 12, 2026
- Bladder EpiCheck Urine TestBladder CancerClinicalTrials.gov · fetched Nov 12, 2026
- Blood collectionCancerClinicalTrials.gov · fetched Nov 12, 2026
- Blood collectionLung CancerClinicalTrials.gov · fetched Nov 12, 2026
- Cystoscopy and pathologyBladder CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials6
- Bladder EpiCheck Product Development StudyRECRUITING · started Sep 15, 2025ClinicalTrials.gov NCT07514143 · fetched Nov 12, 2026
- Lung EpiCheck Biomarkers Development StudyCOMPLETED · started May 17, 2022ClinicalTrials.gov NCT06245876 · fetched Nov 12, 2026
- Determination and Validation of a Multi-analyte Assay for Lung Cancer ScreeningCOMPLETED · started Sep 17, 2021ClinicalTrials.gov NCT04968548 · fetched Nov 12, 2026
- Analytical Specificity of Bladder EpiCheck Test in Healthy Population and Urology Patients Without Prior History or Evidence of Bladder CancerCOMPLETED · started Sep 5, 2019ClinicalTrials.gov NCT06020807 · fetched Nov 12, 2026
- Characterization of Methylation Patterns in Cancer and Non-Cancer cfDNACOMPLETED · started Apr 17, 2019ClinicalTrials.gov NCT04264767 · fetched Nov 12, 2026
- The Efficacy of the Bladder EpiCheck for Detection of Recurrent Urothelial Cell CarcinomaNA · COMPLETED · started Sep 1, 2016ClinicalTrials.gov NCT02700464 · fetched Nov 12, 2026